Array BioPharma Competitors and Similar CompaniesClear all

Avid Bioservices's competitors and similar companies include Amicus Therapeutics and Durect.
Avid Bioservices
Avid Bioservices
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Founding Date
Founding Date
1981
Founding Date
2002
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tustin, US HQ
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Cupertino, US HQ
Employees
Employees
21114% increase
Employees
58415% increase
Employees
902% increase
Valuation ($)
Valuation ($)
649.4 m
Valuation ($)
3.4 b
Valuation ($)
45.3 m

Financial

Revenue (est.)
Revenue (est.)
$139.9m (FY, 2024)
Revenue (est.)
$634.2m (FY, 2025)
Revenue (est.)
$2m (FY, 2024)
Cost of goods
Cost of goods
$132.6m (FY, 2024)
Cost of goods
$72.9m (FY, 2025)
Cost of goods
$78k (FY, 2024)
Gross profit
Gross profit
$7.3m (FY, 2024)
Gross profit
$561.3m (FY, 2025)
Gross profit
$2m (FY, 2024)
Net income
Net income
($140.8m) (FY, 2024)
Net income
($27.1m) (FY, 2025)
Net income
($8.3m) (FY, 2024)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
$ 20m
For sources of this data, please see the company profile

View Company Profiles

Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.

View company